REG3α可作为克罗恩病复杂病程的预测生物标志物
该研究评估血清再生胰岛衍生蛋白3α(REG3α)与克罗恩病(CD)进展的关联。在394例患者中,高血清REG3α与CD进展独立相关(Mt Sinai:HR 1.9,95%CI 1.3-2.8;Leuven:HR 2.9,95%CI 1.9-4.6;均P<.001),且在诊断前队列中可预测复杂和手术型CD。
要点
- 高血清REG3α与CD进展独立相关,不受CRP和内镜活动度影响。
- 诊断前高血清REG3α可预测复杂(B2/3)和手术型CD。
- CD与再生型潘氏细胞群丢失及REG3α表达群富集相关。
核心结论
- 血清REG3α有望作为CD的非侵入性预后生物标志物,独立于疾病活动度。
- 高血清REG3α甚至可在诊断前数年预测复杂病程。
研究设计与样本
- 两个横断面队列(Mount Sinai、Leuven)和一个诊断前队列(PREDICTS),共394例患者。
- PREDICTS队列包含诊断前长达10年的系列血清样本。
- 通过bulk RNA测序评估配对回肠和结肠活检的组织REG3α表达,并用单细胞RNA测序数据探索机制。
主要发现
- 在394例患者中,高血清REG3α与CD进展相关,独立于C反应蛋白和内镜活动度(Mt Sinai:HR 1.9,95%CI 1.3-2.8;Leuven:HR 2.9,95%CI 1.9-4.6;均P<.001)。
- 该关联在轻度或非活动性CD患者中持续存在。
- 在诊断前队列中,高血清REG3α预测CD发生,尤其是复杂(B2/3)和手术表现,可早至诊断前10年(P)。
- 组织REG3α表达和潘氏细胞转录组分析提示CD与再生型潘氏细胞群丢失及REG3α表达群富集相关。
临床怎么用
- 血清REG3α或可用于CD风险分层,识别可能进展为复杂病程的患者。
- 高REG3α患者即使疾病活动度低,也应警惕进展风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Regenerating islet-derived 3α (REG3α) is a serum biomarker in patients with graft-vs-host disease linked to 6-month mortality. REG3α is produced by intestinal Paneth cells, which are implicated in Crohn's disease (CD) pathophysiology. The aim of this study was to assess associations between serum REG3α and progressive CD. METHODS: Serum REG3α was measured in 2 cross-sectional (Mount Sinai, Leuven) and a prediagnostic cohort (PREDICTS) with serial samples up to 10 years before CD diagnosis. Tissue REG3α expression was assessed via bulk RNA sequencing from paired ileal and colonic biopsies. Serum REG3α and tissue REG3α were associated with CD progression (hospitalization, surgery, steroid course, or new advanced therapy). Single-cell RNA sequencing data explored associations between REG3α expression, Paneth cell phenotypes, and CD. RESULTS: In 394 patients, high serum REG3α was associated with CD progression, independent of C-reactive protein and endoscopic activity (Mt Sinai: hazard ratio [HR], 1.9; (95% confidence interval [CI], 1.3-2.8; Leuven: HR, 2.9; 95% CI, 1.9-4.6; both P < .001). The association persisted in patients with mild or inactive CD. In the prediagnostic cohort, high serum REG3α predicted the development of CD, particularly complicated (B2/3) and surgical presentations, up to 10 years before diagnosis (P). Analysis of REG3α expression and Paneth cell transcriptomes suggested that CD is associated with loss of regenerative Paneth cell populations and enrichment in REG3α-expressing populations, suggesting a mechanism through which changes in serum REG3α associate with complicated CD. CONCLUSIONS: Serum REG3α holds potential as a noninvasive, prognostic biomarker in CD, independent of disease activity. High serum REG3α, even years before diagnosis, is linked to a complicated disease course.
引用
- Claytor JD, D'Hooghe AT, Bourgonje AR, et al. Regenerating Islet-Derived 3α Is a Predictive Biomarker of Complicated Disease From Preclinical Through Established Crohn's Disease. Clin Gastroenterol Hepatol. 2026. PMID: 42685961. doi:10.1016/j.cgh.2026.08.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。